This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Miami. Active years: 2017-2021.
Company Filing History:
Years Active: 2017-2021
Title: Innovations of Samia Q Khan
Introduction
Samia Q Khan is a prominent inventor based in Miami, FL (US). She has made significant contributions to the field of immunology through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the regulation of T regulatory cells and the treatment of diseases associated with antigen-specific immune responses.
Latest Patents
Samia Q Khan's latest patents include compositions comprising TLIA-Ig fusion protein for the regulation of T regulatory cells. These compositions are designed for use in treating diseases and disorders linked to antigen-specific immune responses. Additionally, her patents describe combination therapies that involve the administration of a TNFRSF25 agonist along with an interleukin, such as IL-2, and/or an mTOR inhibitor like rapamycin.
Career Highlights
Samia Q Khan is affiliated with the University of Miami, where she continues her research and development in immunology. Her work has garnered attention for its potential applications in therapeutic settings, particularly in enhancing immune responses.
Collaborations
Some of her notable coworkers include Eckhard R Podack and Taylor H Schreiber, who contribute to her research endeavors and collaborative projects.
Conclusion
Samia Q Khan's innovative work in the field of immunology, particularly her patented compositions and methods, showcases her dedication to advancing medical science. Her contributions have the potential to significantly impact the treatment of immune-related diseases.